Lv11
30 积分 2025-08-17 加入
The Pitfalls of CA19-9
2小时前
已完结
Distribution of CA 19-9 in Adenocarcinomas and Transitional Cell Carcinomas: An Immunohistochemical Study of 527 Cases
3小时前
已完结
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice
1天前
已完结
The Pitfalls of CA19-9
4天前
已完结
257 Heterogeneous expression of A33 in colorectal cancer: Possible explanation for A33 antibody treatment failure
16天前
已完结
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial
20天前
已完结
Claudin 18.2 as a novel therapeutic target
1个月前
已完结
Claudin 18.2 as a novel therapeutic target
1个月前
已完结
Subtyping for pancreatic cancer precision therapy
1个月前
已完结
A phase 1 study of LY3076226, a fibroblast growth factor receptor 3 (FGFR3) antibody–drug conjugate, in patients with advanced or metastatic cancer
1个月前
已完结
皖公网安备34019202002308
